Your browser is no longer supported. Please, upgrade your browser.
Settings
AWH [NASD]
Aspira Women's Health Inc.
Index- P/E- EPS (ttm)-0.18 Insider Own1.00% Shs Outstand104.23M Perf Week-7.63%
Market Cap677.26M Forward P/E- EPS next Y-0.90 Insider Trans0.00% Shs Float57.88M Perf Month-22.14%
Income-17.90M PEG- EPS next Q-0.23 Inst Own27.00% Short Float18.83% Perf Quarter-5.14%
Sales4.70M P/S144.10 EPS this Y-1.00% Inst Trans0.16% Short Ratio12.14 Perf Half Y90.92%
Book/sh0.09 P/B66.61 EPS next Y1.10% ROA-111.40% Target Price- Perf Year537.77%
Cash/sh0.15 P/C40.80 EPS next 5Y- ROE-194.40% 52W Range0.90 - 10.54 Perf YTD-10.66%
Dividend- P/FCF- EPS past 5Y15.20% ROI-124.90% 52W High-40.04% Beta3.24
Dividend %- Quick Ratio2.90 Sales past 5Y16.40% Gross Margin26.60% 52W Low599.89% ATR0.54
Employees68 Current Ratio2.90 Sales Q/Q7.70% Oper. Margin- RSI (14)42.22 Volatility4.38% 7.96%
OptionableYes Debt/Eq0.48 EPS Q/Q-67.60% Profit Margin- Rel Volume0.34 Prev Close5.99
ShortableYes LT Debt/Eq0.32 EarningsMar 25 AMC Payout- Avg Volume897.54K Price6.32
Recom1.70 SMA20-8.36% SMA50-15.70% SMA20024.75% Volume304,199 Change5.42%
Mar-29-21Initiated Truist Buy $12
Jan-29-21Initiated Cantor Fitzgerald Overweight $10
Oct-30-20Initiated William Blair Outperform
Mar-30-21 02:00AM  
Mar-26-21 09:38AM  
Mar-25-21 04:20PM  
04:01PM  
02:30PM  
Mar-18-21 12:30PM  
08:00AM  
Mar-15-21 08:00AM  
Feb-22-21 08:30AM  
Feb-17-21 08:00AM  
Feb-12-21 04:18PM  
Feb-10-21 05:38PM  
Feb-04-21 09:25AM  
Feb-03-21 04:03PM  
02:49AM  
Jan-28-21 08:00AM  
Jan-04-21 04:34PM  
Dec-20-20 01:27AM  
Nov-29-20 08:24PM  
Nov-19-20 08:00AM  
Nov-14-20 07:24AM  
Nov-12-20 04:01PM  
02:30PM  
Nov-10-20 08:30AM  
Nov-09-20 08:00AM  
Nov-05-20 08:00AM  
Nov-04-20 08:00AM  
Oct-28-20 08:00AM  
Oct-14-20 08:00AM  
Oct-09-20 08:00AM  
Oct-08-20 03:30PM  
Oct-06-20 07:57AM  
Sep-28-20 08:30AM  
Sep-15-20 05:01PM  
Sep-08-20 11:44AM  
Aug-22-20 10:01AM  
Aug-14-20 03:51PM  
Aug-13-20 04:01PM  
Jul-31-20 09:23AM  
Jul-08-20 06:30AM  
Jul-01-20 11:23AM  
Jun-29-20 08:00AM  
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, the company is developing diagnostic algorithms; and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test; and an agreement with Dana Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer. The company has a strategic alliance with Quest Diagnostics, Incorporated. It serves physician office and hospital laboratories, as well as physicians. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHREIBER DAVIDDirectorSep 08Sale2.7850,000139,000185,018Sep 10 05:35 PM
SCHULER JACK W10% OwnerJul 01Buy3.502,285,7158,000,00225,394,517Jul 06 05:25 PM